# Effect of Liraglutide vs CPAP on Cardiometabolic Outcomes in Obstructive Sleep Apnea

> **NCT04186494** · NA · COMPLETED · sponsor: **St Vincent's University Hospital, Ireland** · enrollment: 30 (actual)

## Conditions studied

- Sleep Apnea, Obstructive

## Interventions

- **DRUG:** Liraglutide (Saxenda) 6Mg/Ml Inj Pen 3Ml
- **DEVICE:** Continuous positive airway pressure treatment
- **COMBINATION_PRODUCT:** Liraglutide and CPAP

## Key facts

- **NCT ID:** NCT04186494
- **Lead sponsor:** St Vincent's University Hospital, Ireland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-02
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-07-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2023-12-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04186494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04186494, "Effect of Liraglutide vs CPAP on Cardiometabolic Outcomes in Obstructive Sleep Apnea". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04186494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*